These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3841395)

  • 1. [Changes in the immune status indices of patients with diffuse toxic goiter in different stages of the disease].
    Livshits AKh; Oleĭnik EK
    Probl Endokrinol (Mosk); 1985; 31(6):6-10. PubMed ID: 3841395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of thyrostatic therapy on various immunologic indices in patients with diffuse toxic goiter].
    Vnotchenko SL; Starkova NT; Mkrtumova NA
    Probl Endokrinol (Mosk); 1983; 29(4):19-23. PubMed ID: 6604271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioimmunological and immunological follow-up of toxic goiter remission following radiotherapy and thyroidectomy].
    Ametov AS; Livshits AKh; Oleĭnik EK
    Med Radiol (Mosk); 1987 Feb; 32(2):38-41. PubMed ID: 3100903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic reactions in patients with diffuse toxic goiter after mercasolyl treatment].
    Epishin AV
    Klin Med (Mosk); 1984 Aug; 62(8):90-3. PubMed ID: 6333549
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological characteristics of patients with diffuse toxic goiter].
    Sekhniashvili ZSh
    Probl Endokrinol (Mosk); 1988; 34(2):3-5. PubMed ID: 2969106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of various indicators of cellular immunity in patients with diffuse toxic goiter after drug therapy].
    Nugmanova LB; Garib FIu; Ismailov SI; Aripov DA
    Probl Endokrinol (Mosk); 1986; 32(3):17-21. PubMed ID: 2874552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics of interleukin 2 production in patients with diffuse toxic goiter under the influence of treatment].
    Shatsova EN; Malaitsev VV; Bogdanova IM
    Probl Endokrinol (Mosk); 1988; 34(6):24-6. PubMed ID: 2976937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of immunological reactivity of patients with diffuse toxic goiter in relation to the duration of the disease].
    Aliev TA; Nasibov AI
    Probl Endokrinol (Mosk); 1986; 32(3):7-10. PubMed ID: 3755533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Ishihara M; Hasegawa Y; Ogata H; Kamoi K; Kaneko K
    Horm Metab Res; 1988 Apr; 20(4):235-8. PubMed ID: 3397034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the clinical picture, hormonal status and humoral immunity in older patients with diffuse toxic goiter].
    Natarov VV; Grinchenko TS; Afanas'eva NI; Pesotskaia PM; Nikolaeva VM
    Ter Arkh; 1988; 60(12):96-8. PubMed ID: 3247664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies to the plasma membranes of thyrocytes in patients with diffuse toxic goiter during treatment with mercazole].
    Saarma VA; Podar TU
    Probl Endokrinol (Mosk); 1988; 34(5):17-9. PubMed ID: 3217382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease: evolution and prognosis after eight months of treatment with methimazole.
    Gauna AT; Guillén CE; Sartorio GC; Soto RJ
    Medicina (B Aires); 1992; 52(3):207-12. PubMed ID: 1364158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK; Yoo WS; Kim DW; Chung HK
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predicting the recurrence of thyrotoxicosis after iodine radioisotope therapy of diffuse toxic goiter].
    Ametov AS; Livshits AKh; Oleĭnik EK
    Probl Endokrinol (Mosk); 1988; 34(1):13-6. PubMed ID: 3362805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methimazole has no dose-related effect on the serum concentrations of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and beta 2-microglobulin in patients with Graves' disease.
    Escobar-Morreale HF; Serrano-Gotarredona J; Villar LM; García-Robles R; González-Porqué P; Sancho JM; Varela C
    Thyroid; 1996 Feb; 6(1):29-36. PubMed ID: 8777381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.